← Back to companies
Sionna Therapeutics
0 open
Natick, Massachusetts, United StatesFounded 201862+ employeesGrowth raisedGrowthSION
Last round: series c · $182M · Mar 2024(2 rounds total)
Founded by Greg Hurlbut, Mark Munson
Backed by(10 investors)
Enavate SciencesOrbiMedViking Global InvestorsQ Healthcare HoldingsThe Rise FundCystic Fibrosis FoundationPerceptive AdvisorsT. Rowe PriceAtlas VentureRA Capital Management
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
Open Positions at Sionna Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Sionna Therapeutics?
